Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Interest & Investment Income (2021 - 2025)

Kezar Life Sciences' Interest & Investment Income history spans 5 years, with the latest figure at $1.0 million for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 49.66% year-over-year to $1.0 million; the TTM value through Sep 2025 reached $5.4 million, down 43.14%, while the annual FY2024 figure was $8.5 million, 23.79% down from the prior year.
  • Interest & Investment Income for Q3 2025 was $1.0 million at Kezar Life Sciences, down from $1.2 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.9 million in Q2 2023 and bottomed at $37000.0 in Q3 2021.
  • The 5-year median for Interest & Investment Income is $1.4 million (2025), against an average of $1.4 million.
  • The largest annual shift saw Interest & Investment Income soared 4304.0% in 2022 before it crashed 49.66% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at $50000.0 in 2021, then skyrocketed by 4304.0% to $2.2 million in 2022, then increased by 23.89% to $2.7 million in 2023, then crashed by 36.44% to $1.7 million in 2024, then crashed by 40.83% to $1.0 million in 2025.
  • Per Business Quant, the three most recent readings for KZR's Interest & Investment Income are $1.0 million (Q3 2025), $1.2 million (Q2 2025), and $1.4 million (Q1 2025).